Synlogic SYBX
OTC SYBX
$1.07 -0.01 (-0.93%)
As of: Oct 21, 2026 · 10:07 AM EDT

Synlogic (SYBX) Cash from Restructuring (2017)

Updated

Analysis

Synlogic (SYBX) Cash from Restructuring (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.56 Bn 1,141.15 Bn 19.71 Bn
2 Johnson & Johnson 637.42 Bn 555.95 Bn 17.26 Bn
3 AbbVie 504.13 Bn 477.24 Bn 12.70 Bn
4 Merck 377.81 Bn 332.19 Bn 12.21 Bn
5 Novartis Ag 304.36 Bn 268.35 Bn 11.24 Bn
6 Astrazeneca 267.51 Bn 241.20 Bn 12.86 Bn
7 Amgen 242.18 Bn 197.58 Bn 7.24 Bn
8 Gilead Sciences 194.29 Bn 168.48 Bn 6.22 Bn
9 Pfizer 172.82 Bn 119.47 Bn 10.94 Bn
10 Synlogic 11.23 Mn -49.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 166,000.00
Mar 31, 2017 2.56 Mn
API Access

Synlogic Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=SYBX&period=max&api_key=YOUR_API_KEY